miRNA-mediated prevention (5)

By: James V. Kohl | Published on: January 15, 2025

Nanocarrier imaging at single-cell resolution across entire mouse bodies with deep learning 1/14/25 links the perfectly predictable effect of modified mRNA from changes in light-matter interactions and the miRNA-mRNA balance to the virus-driven degradation of mRNA in all cell types of all tissues in all organisms of all species.

“We demonstrate that intramuscularly injected LNPs carrying SARS-CoV-2 spike mRNA reach heart tissue, leading to proteome changes, suggesting immune activation and blood vessel damage. SCP-Nano generalizes to various types of nanocarriers, including liposomes, polyplexes, DNA origami and adeno-associated viruses (AAVs), revealing that an AAV2 variant transduces adipocytes throughout the body.”

Nothing screams “You Fools” louder than attempts to alter the conserved molecular mechanisms of cell type differentiation across species and profit from injections that prevent naturally occurring energy-dependent miRNA-mediated DNA repair at the level of hydrogen-atom transfer in DNA base pairs in solution.

That explains why Facebook removed my post on the effectiveness of GLP-1 agonists that biophysically constrain viral latency across kingdoms via Glucose Metabolism Acts as a Compass to Guide Embryonic Development 10/18/24 and the transgenerational epigenetic inheritance of ecological adaptations linked to Genetic Ancestryโ€“Based Differences in Biomarker-Based Eligibility for Precision Oncology Therapies 1/9/25

I linked to an article about the 2024 top developments in health care with a focus on energy-dependent miRNA-mediated peptide synthesis at the origin of life, and glucagon-like peptide-1 receptor antagonists that appear to prevent all virus-driven pathology.

Lowering virus-driven disease risk profits no one. Capitalism requires that shareholders continue to profit from unnecessary suffering and premature deaths.

See also: MiRNAs: main players of cancer drug resistance target ABC transporters 1/14/25

“…microRNAs (miRNAs) have demonstrated potential in modulating chemoresistance by specifically targeting ABC transporters, thereby offering promising new avenues for overcoming drug resistance. This narrative review aims to elucidate the molecular underpinnings of drug resistance, with a particular focus on the roles of ABC transporters and the regulatory influence of miRNAs on these transporters.”


Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments

Want more on the same topic?

Swipe/Drag Left and Right To Browse Related Posts: